After becoming an epigenetics convert four years ago at Lorne and winning the Eppendorf Young Investigator's Award there two years ago, Dr Jeff Craig returns to Lorne in 2008 as an invited speaker to present the fruits of his conversion.

Eppendorf has introduced the first filter tip that provides a two-phase filter for contamination protection.

The share price of Queensland biotech company Progen Industries has almost tripled in less than six months following promising Phase II clinical trial results for its lead cancer compound and the expectation of more good news in the near future.

'Automate' has become the new mantra for life science technology innovators, writes Malorye Branca.

Progen (ASX:PGL) has sold its life sciences business unit to New Zealand-based Global Science and Technology (GST) for AUD$1.2 million.

The consumables market in Australia has long been supported by the lab, mining and agricultural customer. But now, biotech is changing the landscape. Faster moving, smaller and more disposable, consumables are making the move to a technology based market. Jeremy Torr reports